To investigate the total antioxidant status (TAS) and the extent of oxidative DNA damage in total lymphocytes and their relation with essential hypertension. A total of 130 South Indian subjects aged 30-65 were recruited for the study. Of these hypertensive subjects investigated, 30 were newly diagnosed and were not on any antihypertensive drugs, but had systolic blood pressure (BP) ranging between 140 and 160 mm Hg and diastolic BP between 95 and 100 mm Hg; 50 hypertensive patients who were already on drug therapy for 1 year and 50 were normotensive controls with BP p120/80 mm Hg. DNA damage was significantly increased in hypertensive patients (both newly diagnosed and who were already on drug therapy) compared with control group. The major increase in DNA damage was observed in newly diagnosed hypertensive patients compared with hypertensive patients who were already on drug therapy. There was a significant decrease in plasma TAS value in essential hypertensive groups as compared to normotensive controls. Lymphocyte DNA damage was independently correlated with only TAS. Lymphocyte DNA damage was increased in hypertensive patients. The major increase in lymphocyte DNA damage was observed in newly diagnosed hypertensive patients compared with hypertensive patients who already on drug therapy. Decreased TAS levels, which reflect to increased oxidative stress, may be the reason of increased total lymphocyte DNA damage in South Indian hypertensive patients.
Introduction
Several lines of evidence suggest that patients with essential hypertension (EH) have impaired balance between oxidant and antioxidant. However, the mechanism underlying these abnormalities and its effect on DNA level remains unknown.
Hypertension is a major health problem in developed as well as developing countries with a common end result of elevated blood pressure (BP). Hypertension is present in 60-70% of the population over 60 years of age and may result in cardiovascular complication such as stroke, coronary heart disease, and heart failure.
EH refers to the high BP with no identifiable causes. It is the most common type of hypertension, affecting 95% of hypertensive patients. It can be diagnosed when the systolic BP ranging between 140 and 160 mm Hg and/or diastolic BP between 95 and 100 mm Hg at three random checks and need medical monitoring and lifestyle changes. 1 Recent experimental evidence suggests that oxidative stress has an important function in the development of high BP in some animal model. 2 It has been proposed that release of oxygen-free radicals would be stimulated by acute hypertension and this increase in oxygen-free radicals might mediate the vascular damage, which can be seen in hypertensive subjects. Oxygen-free radicals are highly reactive and can react with cellular membranes damaging them through lipid peroxidation. 3 The comet assay has been extensively used for human biomonitoring studies. Lymphocytes are the preferred cell type as they are an internationally accepted indicator tissue to asses the consequence of human exposure to genotoxic hazard 4, 5 and it is a simple, sensitive, rapid technique for the assessment of DNA damage and also they allow the assay to be non-invasive.
Peripheral lymphocyte DNA damage is caused by multiple factors including, oxidative stress 6, 7 mainly and the other causes such as coronary artery diseases 8 and inflammation. 9 It has been shown that DNA damage contributes significantly to the development and progression of atherosclerosis. 10 Although increased levels of reactive oxygen species (ROS) 11, 12 and decreased antioxidant capacity were investigated, the relationship between lymphocyte DNA damage and total antioxidant status (TAS) has not been investigated in both newly diagnosed and during therapy of essential hypertensive patients, so far.
In group 3 (during therapy), the entire patients received different antihypertensive drug with various combination. In this group we are not looking for single drug and its effect. On the whole, the complete status of antihypertensive drug effect over oxidative stress in essential hypertensive patients was seen.
In Dr KM Cherian Heart Foundation, the following drugs were given (Prolomet XL (b blocker), Telmisartan (Angiotensin II receptor antagonist), Amlodipine and Nifedipine (calcium channel blocker), Natrilix SR (diuretics), Captopril (ACE inhibitor), Doxazosin (a blocker), and Carvedilol (both a and b blockers).
The goal of this study was to investigate the relationship between lymphocyte DNA damage and TAS in newly diagnosed hypertensive patients and in patients already on drug therapy.
Materials and methods

Subjects
The study design included three groups of human subjects as participants. A total of 80 essential hypertensive cases were studied. Among these 30 were newly diagnosed essential hypertensive patients without any previous history of antihypertensive medication, and 50 patients who were already on drug therapy for 1 year; 50 were age and sex matched normotensive controls without any family history of hypertension were also studied for comparison. Hypertension was diagnosed when the systolic and diastolic pressure read 140 and 90 mm Hg, respectively, at three random checks.
These subjects were enroled from Dr KM Cherian Heart Foundation, Chennai, India. All the participants underwent a detailed clinical examination. Different parameters such as age, BP, Hb, and ECG were recorded. The study was approved by both research and ethics committee of our institute. A fully informed consent was obtained from these subjects before participation in the study.
Subject selection criteria Inclusion criteria
All volunteers enroled in this study were aged between 30 and 65years.
Subjects of both sexes were included. Women, being on a regular menstrual cycle were included in the study. Newly diagnosed EHT patients without any previous history of antihypertensive medication were included in group 2. EHT patients who were on antihypertensive drug for 1 year±2 months were included in group 3.
Exclusion criteria. Subjects with secondary hypertension, past history of stroke, coronary artery disease, myocardial infarction, and peripheral vascular disease with evidence of tissue injury or loss, renal diseases, diabetes mellitus, after infections, smokers, alcoholic and who with vitamin supplement, known to cause changes in antioxidant and lipid status, were excluded from the study.
Blood sample collection
Peripheral venous blood samples of 3 ml were drawn from all the subjects in the fasting state and placed in heparinized tubes. Heparinized blood of 1 ml was pipetted into another tube immediately to measure DNA damage. The remaining blood was centrifuged at 3000 r.p.m. Â 10 min for plasma separation. Plasma samples were used for the analysis of TAS, lipid profile, and glucose. Plasma samples were stored at À80 1C for TAS analysis.
Measurement of biochemical markers
Plasma triglyceride, total cholesterol, LDL, HDL, and fasting glucose concentration were measured with an auto analyzer (Randox Daytona, Nishinomiya, Japan, clinical biochemistry analyzer) by using commercial kits.
Comet assay-oxidative DNA damage determination The endogenous lymphocytes DNA damage was analysed by alkaline comet assay by the method of Singh et al. 13 with minor modifications.
Separation of total lymphocytes. Lymphocyte isolation for the comet assay was performed by using the Histopaque 1077 (Sigma, St Louis, MO, USA). An amount of 1 ml heparinized blood was carefully layered over 1 ml Histopaque and centrifuged for 35 min at 500 g at 25 1C. The interface band containing lymphocyte was washed with phosphate buffer saline and then collected by 15 min centrifugation at 400 g. The resulting pellets were resuspended in phosphate buffer saline to obtain 20 000 cells in 10 ml.
Cell viability test. Membrane integrity of lymphocyte cells was assessed by using Trypan Blue exclusion method.
1. An amount of 10 ml sample and 5 ml of trypan blue dye were taken in a micro centrifuge tube. 2. It was allowed to stand for 2 min and placed on a slide and then with coverslip.
Hundred cells were scored and the number of viable cells (shiny) and dead cells (blue) was
recorded.
An amount of 10 ml fresh lymphocyte cell suspension (around 20 000 cells) was mixed with 80 ml of 0.7% low melting point agarose (Sigma) in phosphate buffer saline at 37 1C. Subsequently, 80 ml of this mixture was layered onto slides that had previously been coated with 1.0% hot normal melting agarose, covered with a coverslip at 4 1C for at least 5 min to allow the agarose to solidify. After removing the coverslips, the slides were submersed in freshly prepared cold (4 1C) lysing solution (2.5 M NaCl, 100 mM EDTA-2Na; 10 mM Tris-HCl, pH 10-10.5; 1% Triton X-100 and 10% DMSO added just before use) for at least 1 h. Slides were then immersed in freshly prepared alkaline electrophoresis buffer (0.3 mol
À1
NaOH and 1 mmol À1 Na 2 EDTA, pH413) at 4 1C for unwinding (30 min) and then electrophoresis was performed (400 mA/24 V, 25 min).
All of the above steps were conducted under red light or dim light to prevent additional DNA damage. After electrophoresis, the slides were stained with ethidium bromide (20 mg ml À1 in distilled water; 80 ml per slide), covered with a coverslip and analysed by using a fluorescence microscope (Olympus, Shinjuku Monolith, Tokyo, Japan).
Scoring of slides. The images of 100 randomly chosen nuclei (50 cells from each of two replicate slides) were analysed visually by manual scoring 14 ( Figure 1 ). Each image was classified according to the intensity of the fluorescence in the comet tail and was given a value of either of 0, 1, 2, 3, or 4 (from undamaged class 0 to maximally damaged class 4), so that the total scores of slide could be between 0 and 400 arbitrary units (AU). All procedures were completed and the extent of DNA damage was detected by a single observer.
Measurement of TAS
TAS of plasma was determined by ferric reducing antioxidant power assay. [15] [16] [17] Briefly, 25 ml of plasma was added to 750 ml of the freshly prepared working solution of 10 volume of 300 mM acetate buffer, pH 3.6 þ 1 volume of 10 mM 2,4,6-tripyridyl-striazine þ 1 volume of 20 mM FeCl 3 , pre-warmed to 37 1C. At low pH, reduction of a ferric tripyridyl triazine (Fe 3 þ -TPTZ) complex to a ferrous form, which had an intense blue colour, was monitored by using spectrophotometer by measuring the absorbance at 593 nm after 5 min incubation at 37 1C. The results were expressed in micro mole per liter.
Statistical analysis
Results are presented as mean±s.d. or frequency expressed as a percent, categorical variables were compared by using w 2 -test. We assessed normality of all study variables through Kolmogorov-Smirnov one sample test (K-S test). Comparison among multiple groups was performed by one-way analysis of variance with LSD post hoc test for continuous variables. Association of lymphocyte DNA damage with demographical, clinical, and antioxidative parameters was assessed by Pearson correlation coefficient. Values of probability o0.05 was considered statistically significant. The statistical analysis was performed with SPSS 10.0 for windows. The statistical power estimated was 94% to detect main effects and a set at 0.05.
Results
The mean TAS and lymphocyte DNA damage of all the three groups are illustrated in Figures 2 and 3 , respectively. The base line characteristics and correlation of the EH patient and control groups are summarized in Table 1 . Total cholesterol, TAG, LDL (Po0.05) were significantly increased in EH patients when compared with controls, whereas HDL (Po0.05) was significantly decreased in EH patients when compared with control group.
Mean lymphocyte DNA damage of EH patient group was found at high level compared with control group (Po0.05) and mean lymphocyte DNA damage of EH-newly diagnosed group was found significantly high compared with EH patientduring therapy (Po0.05). Mean TAS of EH patient group was significantly lower than control group (Po0.05). Mean TAS of EH-newly diagnosed was found to be significantly lower when compared with EH patient-during therapy (Po0.05).
In EH-during therapy group the lymphocyte DNA damage was correlated with other variables such as age, glucose, lipid profile, and TAS was demonstrated in Table 2 . Lymphocyte DNA damage was independently correlated only with TAS and it is highly significant (Po0.0001). The correlation of lymphocyte DNA damage with TAS of all the three groups was illustrated in Figure 4 .
Discussion
Our data clearly show that oxidative DNA damage occurs in essential hypertensive patients more than in normal BP subjects and that the oxidative DNA damage is significantly diminished by the administration of antihypertensive drugs for the period of one year. To the best of our knowledge, this study is the first report in South Indian Population to evaluate the association between lymphocyte DNA damage and TAS in both newly diagnosed essential hypertensive patients and who were already on drug therapy for 1 year.
As alkaline comet assay is a sensitive technique for the assessment of DNA damage in an individual cell; it has been shown that oxidative stress in EH influences the comet assay responses in lymphocyte. As the lymphocytes are readily available and widely used as a sentinel cell type to provide early warning signals for adverse effects, an attempt was made to see whether oxidative stress in essential hypertensive patients subsides after Oxidative stress because of excessive production of ROS outstripping antioxidant defence mechanism has been implicated in many pathophysiological conditions that affect the cardiovascular system, such as hypercholesterolemia, diabetes, and hypertension. 18, 19 Decreased antioxidant capacity 20 and increased ROS release 21 were shown to be associated with EH.
It is well known that DNA damage frequently occurs in cells exposed to oxidative stress. 22 Increased oxidative status may initiate lipid peroxidation in cell membranes, damage membrane proteins, or cause DNA fragmentation. These processes may result in a loss of heart contractile function and lead to severe myocardial cell damage. 23 Antioxidant systems (such as TAS) prevent DNA damage. Honda et al. 24 reported that reduced activities of the antioxidant enzymes were associated with increased levels of oxidative DNA damage. However, in this study, the TAS levels, which provide a measure of total defences against ROS, were found at low level in hypertensive patients. Corroborating our preliminary observations, this study provided evidence that oxidative DNA damage was associated with depletion of extracellular antioxidants in essential hypertensive patients. Moreover, TAS assay reflects a general antioxidant capacity of plasma to which protein thiols mainly contribute. Several studies indicate that uric acid and ascorbic acid constitute around half the total antioxidant activity. Looking for possible reasons for the behaviour of TAS, it is necessary to take into account the results of Wayner et al., who showed that the antioxidant efficiency of ascorbate is concentration dependent. 25 The limitation of this study is only TAS was evaluated. Other antioxidants and oxidative markers and their relationship with lymphocyte DNA damage may be investigated in the future.
Pathophysiological effect of oxidative DNA damage in vascular diseases should be importantly considered because decreased TAS levels, which reflect increased vascular oxidative stress, may be the reason for increased lymphocyte DNA damage in hypertensive patients (particularly in newly diagnosed EH patients). The above results showed that ROS might be critical in the early stages of human HT, which may represent a novel pathophysiological mechanism for increased risk of cardiovascular diseases and target organ damage in patients with EH. Therefore, this study has additional clinical implication.
Experimental evidence supporting a role for oxidative stress in vascular diseases and hypertension is convincing. Physiologically, ROS are produced in a controlled manner at low concentrations and function as signalling molecules 26 to maintain vascular integrity by regulating endothelial function and vascular contraction-relaxation. Under pathological conditions, increased ROS bioactivity leads to endothelial dysfunction, increased contractility, vascular smooth muscle cells growth, monocyte invasion, lipid peroxidation, inflammation, and increased deposition of extracellular matrix proteins, important factors in hypertensive vascular damage. 27, 28 Despite the preponderance of evidence for the association of increased oxidative stress with various vascular diseases, using antioxidants to prevent CVD has produced mixed outcomes. 29, 30 This article highlights current developments in the field of ROS and hypertension, focusing specifically on the role of oxidative stress in hypertensionassociated vascular damage. Vascular oxidative stress has also been demonstrated in experimentally induced hypertension, such as Ang II-mediated hypertension, Dahl salt-sensitive hypertension, lead-induced hypertension, obesity-associated hypertension, mineralocorticoid hypertension, and aldosterone-provoked hypertension. In view of present data, it is seen that increased oxidative DNA damage and decreased serum TAS level were frequently observed in the newly diagnosed essential hypertensive patients, suggesting that oxidative stress is important in the pathogenesis of EH. Consequently, prevention of DNA damage may be inadequate in hypertensive patients with particularly newly diagnosed EH patients. Furthermore, in this group, presence of low level of TAS and high level of lymphocyte DNA damage may be plausible.
In conclusion, it is likely that DNA damage caused by ROS occurs more in newly diagnosed essential hypertensive patients than in persons with normal BP. Thus, the study shows that EH is associated with increased oxidative stress and reduced antioxidant status. Adequate control of BP with antihypertensive therapy decreases oxidative DNA damage and improves the antioxidant status in essential hypertensive patients. The potential role of antihypertensive drugs as modulators of vascular oxidative stress is currently an area of active research. Arbitrary unit. *P-value significant compared with HT-newly diagnosed vs HT-during therapy (Po0.05).
z P-value significant compared with control vs HT-during therapy (Po0.05).
f P-value significant compared with control vs HT-newly diagnosed (Po0.05).
One-way ANOVA and LSD post hoc were used to derive the P-value. Figure 4 The correlation of lymphocyte DNA damage with TAS. The total lymphocyte DNA damage was negatively correlated with TAS and the P-value was highly significant (Po0.0001) in all the three groups, respectively (control, EH-newly diagnosed, and EH-during therapy).
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Clinical perspective
EH may leads to severe complication and causes the most troublesome problem in humans. Therefore, we should focus on the prevention of development of EH as well as on the reduction of the complication of hypertension. Oxidative damage is closely related to the development and complication of EH. Furthermore, hypertension is one of the most important risk factors of atherosclerosis. Doctors do not know in their daily practice who might have more serious oxidative damage, especially DNA damage, among hypertensive patients. Therefore, we need simple, accurate, and specific method such as COMET assay for oxidative DNA damage so that we can use the appropriate drug for antihypertensive medications, for hypertension patients who have more DNA damage.
Accordingly, it remains within the future scope to see the beneficial effects of antioxidants in combination with antihypertensive drug on oxidative DNA damaged in essential hypertensive patients and a large clinical trial might be needed.
What is known about this topic K TAS is significantly reduced in essential hypertension because of increased production of reactive oxygen species. K We evaluated whether estimation of lymphocyte DNA damage serves as Marker to predict the extent of cellular oxidative stress in essential hypertension.
What this study adds K Decreased TAS level, which reflects to increased oxidative stress, may be the reason of increased lymphocyte DNA damage in South Indian hypertensive patients. K This study clearly showed that patients suffering with essential hypertension are vulnerable to oxidative stress and have impaired status of antioxidant and free radicals. K Thus, the study shows that essential hypertension is associated with increased oxidative stress and reduced antioxidant status. Adequate control of blood pressure with antihypertensive therapy decreases oxidative stress and improves the antioxidant status in those patients.
